CEP55 Antikörper (AA 1-464)

Produktnummer ABIN565830

Dieses Anti-CEP55-Antikörper ist ein Maus Polyklonal-Antikörper zur Detektion von CEP55 in WB und ELISA. Geeignet für Human. Dieses Primary Antibody wurde in 7+ Publikationen zitiert.

Kurzübersicht für CEP55 Antikörper (AA 1-464) (ABIN565830)

Target: CEP55 (Centrosomal Protein 55kDa (CEP55))

Reaktivität: Human

Wirt: Maus

Klonalität: Polyklonal

Konjugat: Dieser CEP55 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Produktdetails anti-CEP55 Antikörper

Bindungsspezifität: AA 1-464

Verwendungszweck: Mouse polyclonal antibody raised against a full-length recombinant CEP55.

Sequenz: MSSRSTKDLI KSKWGSKPSN SKSETTLEKL KGEIAHLKAS VDEITSGKGK LTDKERHRLL EKIRVLEAEK EKNAYQLTEK DKEIQRLRDQ LKARYSTTAL LEQLEETTRE GERREQVLKA LSEEKDVLKQ QLSAATSRIA ELESKTNTLR LSQTVAPNCF NSSINNIHEM EIQLKDALEK NQQWLVYDQQ REVYVKGLLA KIFELEKKTE TAAHSLPQQT KKPESEGYLQ EEKQKCYNDL LASAKKDLEV ERQTITQLSF ELSEFRRKYE ETQKEVHNLN QLLYSQRRAD VQHLEDDRHK TEKIQKLREE NDIARGKLEE EKKRSEELLS QVQFLYTSLL KQQEEQTRVA LLEQQMQACT LDFENEKLDR QHVQHQLLVI LKELRKARNQ ITQLESLKQL HEFAITEPLV TFQGETENRE KVAASPKSPT AALNESLVEC PKCNIQYPAT EHRDLLVHVE YCSK

Kreuzreaktivität: Human

Produktmerkmale: Antibody Reactive Against Recombinant Protein.

Immunogen: CEP55 (AAH08947, 1 a.a. ~ 464 a.a) full-length recombinant protein with GST tag.

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: 50 % glycerol

Handhabung: Aliquot to avoid repeated freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

Referenzen für anti-CEP55 Antikörper (ABIN565830)

Hu, Coughlin, Mitchison: "Midbody assembly and its regulation during cytokinesis." in: Molecular biology of the cell, Vol. 23, Issue 6, pp. 1024-34, (2012) (PubMed).

Hu, Ozlü, Coughlin, Steen, Mitchison: "Plk1 negatively regulates PRC1 to prevent premature midzone formation before cytokinesis." in: Molecular biology of the cell, Vol. 23, Issue 14, pp. 2702-11, (2012) (PubMed).

Kuo, Chen, Baron, Onder, Loewer, Almeida, Weismann, Xu, Houghton, Gao, Daley, Doxsey: "Midbody accumulation through evasion of autophagy contributes to cellular reprogramming and tumorigenicity." in: Nature cell biology, Vol. 13, Issue 10, pp. 1214-23, (2011) (PubMed).

Sagona, Nezis, Pedersen, Liestøl, Poulton, Rusten, Skotheim, Raiborg, Stenmark: "PtdIns(3)P controls cytokinesis through KIF13A-mediated recruitment of FYVE-CENT to the midbody." in: Nature cell biology, Vol. 12, Issue 4, pp. 362-71, (2010) (PubMed).

Agromayor, Carlton, Phelan, Matthews, Carlin, Ameer-Beg, Bowers, Martin-Serrano: "Essential role of hIST1 in cytokinesis." in: Molecular biology of the cell, Vol. 20, Issue 5, pp. 1374-87, (2009) (PubMed).

Chen, Chien, Huang, Hwang, Chuang, Fang, Huang, Chen, Liu, Huang: "Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity." in: Oncogene, Vol. 28, Issue 30, pp. 2723-37, (2009) (PubMed).

Carlton, Agromayor, Martin-Serrano: "Differential requirements for Alix and ESCRT-III in cytokinesis and HIV-1 release." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 30, pp. 10541-6, (2008) (PubMed).

Details zu CEP55

Target: CEP55 (Centrosomal Protein 55kDa (CEP55))

Andere Bezeichnung: CEP55

Hintergrund: Full Gene Name: centrosomal protein 55 kDa
Synonyms: C10orf3,FLJ10540,URCC6

Gen-ID: 55165